Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Mid-range Performer
3051.8000 -62.70 (-2.01%)
NSE Nov 28, 2025 15:31 PM
Volume: 195.8K
 

3051.80
-2.01%
Emkay
DLPL posted a robust quarter, with revenue growing 11% YoY on the back of
sample volume increasing 9% YoY and Swasthfit contributing 24% to the
topline.
Dr. Lal Pathlabs Ltd. has an average target of 3111.40 from 5 brokers.
More from Dr. Lal Pathlabs Ltd.
Recommended